James F. Cleary, MD, on Global Access to Opioids
2016 Palliative Care in Oncology Symposium
James F. Cleary, MD, of the University of Wisconsin Carbone Cancer Center, talks about the many reasons that 80% of the world’s population lacks access to opioids, the mainstay of cancer pain management.
Scott A. Irwin, MD, PhD, of Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute, discusses delirium—its definition, prevalence, consequences, assessment, and management.
Eric Roeland, MD, of the University of California, San Diego, discusses the key papers presented at this year’s Palliative Care in Oncology Symposium.
Jennifer S. Temel, MD, of Massachusetts General Hospital, discusses increasing prognostic uncertainty in light of targeted treatments and immunotherapies, and the difficulty predicting who will benefit.
Tracy A. Balboni, MD, MPH, of the Dana-Farber Cancer Institute, talks about how to preserve quality of life in the presence of complex spinal lesions, including novel ways to assess spinal instability and treat metastases.
Charles D. Blanke, MD, of the Oregon Health & Science University and Southwest Oncology Group, discusses the nearly 20 years’ experience with Oregon’s Death With Dignity (DWD) Act, a voter initiative that led to the first such law enacted in the United States (Abstract 44).